Holen Sie sich die Stockscreener-App
2.72
0.73%
0.02
Aileron Therapeutics Inc Aktie (ALRN) Neueste Nachrichten
University of Texas Texas AM Investment Management Co. Makes New Investment in Aileron Therapeutics, Inc. (NASDAQ:ALRN) - MarketBeat
Aileron Therapeutics reports voting results from annual meeting - Investing.com
Aileron Therapeutics to Present at the 8th Annual IPF Summit - Citizentribune
ALRN Stock Earnings: Aileron Therapeutics Misses EPS for Q2 2024 - MSN
Aileron Therapeutics to Present at the 8th Annual IPF Summit - PR Newswire
Analysts Issue Forecasts for Aileron Therapeutics, Inc.’s FY2024 Earnings (NASDAQ:ALRN) - Defense World
Short Interest in Aileron Therapeutics, Inc. (NASDAQ:ALRN) Declines By 12.8% - Defense World
Aileron Therapeutics to Present at the 8th Annual IPF Summit - StockTitan
Aileron Therapeutics (NASDAQ:ALRN) Issues Quarterly Earnings Results - Defense World
Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights - Winchester Herald Chronicle
Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights - PR Newswire
Aileron Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference - StockTitan
Aileron Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference - Yahoo Finance
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Update - Defense World
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Sees Significant Growth in Short Interest - MarketBeat
Aileron Therapeutics Announces Equity Distribution Agreement - Investing.com India
Aileron Therapeutics Announces Equity Distribution Agreement By Investing.com - Investing.com Canada
Short Interest in Aileron Therapeutics, Inc. (NASDAQ:ALRN) Increases By 94.4% - American Banking and Market News
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Update - MarketBeat
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Sees Significant Growth in Short Interest - Defense World
Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event - Quantisnow
Imunon (NASDAQ:IMNN) versus Aileron Therapeutics (NASDAQ:ALRN) Head-To-Head Contrast - Defense World
Constrained Peptide Drugs Market Price Trends Analysis Aileron Therapeutics, Inc, Bicycle Therapeutics, PLC ... - Economica
Aileron Therapeutics to be Included in the Russell Microcap® Index - Morningstar
Aileron Therapeutics to be Included in the Russell Microcap® Index - BioSpace
Short Interest in Aileron Therapeutics, Inc. (NASDAQ:ALRN) Drops By 41.3% - Defense World
Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under ... - Quantisnow
How does Aileron Therapeutics Inc (ALRN) change from a tortoise to a hare? – Sete News - SETE News
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Major Shareholder Of Texas/Texas Am I. University Sells 4707 Shares - Defense World
University of Texas/Texas A&M sells Aileron Therapeutics shares worth over $21k - Investing.com India
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Major Shareholder Of Texas/Texas Am I. University Sells 4,707 Shares - MarketBeat
Natera co-founder Sheena Jonathan sells shares worth over $296k By Investing.com - Investing.com
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Down 6.9% in May - MarketBeat
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Sees Significant Decrease in Short Interest - Defense World
Of Texas/Texas Am I. University Sells 9342 Shares of Aileron Therapeutics, Inc. (NASDAQ:ALRN) Stock - Defense World
Of Texas/Texas Am I. University Sells 9577 Shares of Aileron Therapeutics, Inc. (NASDAQ:ALRN) Stock - Defense World
University of Texas/Texas A&M sells Aileron Therapeutics stock - Investing.com India
Of Texas/Texas Am I. University Sells 9,342 Shares of Aileron Therapeutics, Inc. (NASDAQ:ALRN) Stock - MarketBeat
University of Texas/Texas A&M sells Aileron Therapeutics stock By Investing.com - Investing.com
TMX Group stock gets PT boost as BMO identifies potential growth catalysts By Investing.com - Investing.com UK
Of Texas/Texas Am I. University Sells 6291 Shares of Aileron Therapeutics, Inc. (NASDAQ:ALRN) Stock - Defense World
University of Texas/Texas A&M sells Aileron Therapeutics shares worth over $40k By Investing.com - Investing.com
Insider Selling: Aileron Therapeutics, Inc. (NASDAQ:ALRN) Major Shareholder Sells 6,291 Shares of Stock - MarketBeat
Aileron Therapeutics (NASDAQ:ALRN) & Eagle Pharmaceuticals (NASDAQ:EGRX) Head to Head Contrast - Defense World
Aileron Therapeutics (NASDAQ:ALRN) Rating Increased to Strong-Buy at Brookline Capital Management - MarketBeat
Are Medical Stocks Lagging Sensus Healthcare (SRTS) This Year? - Yahoo Canada Finance
Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - br.ADVFN.com
Are Medical Stocks Lagging Sensus Healthcare (SRTS) This Year? - Yahoo Finance
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Sees Large Increase in Short Interest - Defense World
Investor's Delight: Aileron Therapeutics Inc (ALRN) Closes Weak at 3.51, Down -4.10 – DWinneX - The Dwinnex
Reviewing Atreca (NASDAQ:BCEL) and Aileron Therapeutics (NASDAQ:ALRN) - Defense World
Aileron Therapeutics (NASDAQ:ALRN) Issues Quarterly Earnings Results - MarketBeat
Chemotherapy Induced Neutropenia Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA ... - Barchart
Aileron Inks Collaboration Deal With Pfizer for Cancer Combo - Yahoo Movies Canada
Aileron Therapeutics Announces New Interim CFO AppointmentTipRanks.com - TipRanks
Aileron Therapeutics Announces New Interim CFO Appointment - TipRanks
Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights - GlobeNewswire
Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights - Yahoo Finance
1.26%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):